Idiopathic Thrombocytopenia Market Intelligence Study: Current...

adicionou um novo artigo Outro

2026-02-25 10:22:40

Idiopathic Thrombocytopenia Market Intelligence Study: Current Scenario and Future Potential

The Idiopathic Thrombocytopenia Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of idiopathic thrombocytopenic purpura (ITP), increased awareness and diagnosis of the condition, and advancements in treatment options. The market is...

0 Comentários 0 Compartilhamentos 7 Visualizações 0 Anterior